You are here
Foreign drug firms in China see approval delays
FOREIGN pharmaceutical companies in China say they are concerned that recent regulatory delays could push back plans to introduce their newest medicines into the country by as many as two years.
At least thirty-four applications from foreign multinationals have been or are
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org